Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Chronic Pain Market Grown from 2024 to 2025?

In recent times, the chronic pain market has experienced significant expansion. The market, projected to augment from $78.79 billion in 2024 to $84.96 billion in 2025, will register a compound annual growth rate (CAGR) of 7.8%. Factors like injury and trauma, surgical procedures, inflammatory conditions, nerve damage, neuropathy, and dearth of effective treatments have been the key drivers for growth during the historic period.

What Growth Rate Is Anticipated for the Chronic Pain Market in the Coming Years?

The market size for chronic pain is projected to experience robust growth in the upcoming years, expanding to $117.74 billion in 2029 with a compound annual growth rate (CAGR) of 8.5%. Factors contributing to this growth during the forecast period include the increasing aging population, the rise of telemedicine, enhanced public health consciousness, advances in genetic research and precision medicine, and psychosocial stressors. Key trends expected during this forecast period encompass the incorporation of wearable devices, the growth of pain education and support groups, the emphasis on holistic pain management, the alternative non-opioid pain management methods, and the use of regenerative medicine for pain control.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11970&type=smp

Who Are the Leading Companies in the Chronic Pain Market?

Major companies operating in the chronic pain market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, Dickinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics

What Are the Key Drivers of the Chronic Pain Market?

The chronic pain market is anticipated to experience growth due to an increase in the number of chronic pain sufferers. These individuals regularly grapple with persistent pain that extends beyond the usual recovery timeframe, typically lasting more than three months. The surge in chronic pain sufferers fuels the expansion of the chronic pain market. The climbing demand for effective pain control solutions, involving pharmaceuticals and medical equipment, generates avenues for innovation and evolution in the field. For example, according to the Australian Institute of Health and Welfare in June 2024, it was estimated that 4.0 million Australians (representing 16% of the population) were living with back issues in 2022. By 2023, back troubles had risen to become the third leading source of disease burden, accounting for 4.3% of the country’s total disease weight. Furthermore, the Institute for Health Metrics and Evaluation, a US-based domestic and international public health organization and research body, reported in February 2024 that anticipated global incidents of neck pain are projected to rise to 269 million by 2050 (ranging from 219 to 322 million), which indicates a 32.5% escalation (between 23.9% and 42.3%) compared to 2020. Hence, the high number of chronic pain sufferers is fueling the expansion of the chronic pain market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11970&type=smp

What Are the Key Market Segments in the Chronic Pain Industry?

The chronic pain market covered in this report is segmented –

1) By Product: Drug, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By End User: Hospitals, Clinics, Research Organization

Subsegments:

1) By Drug: Non-Opioid Analgesics, Opioids, Antidepressants, Anticonvulsants, Topical Analgesics, Corticosteroids

2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units, Spinal Cord Stimulators, Intrathecal Drug Delivery Systems, Heat And Cold Therapy Devices, Bioelectronic Devices

What Are the Latest Trends in the Chronic Pain Market?

The rise of alternative techniques for pain management is a significant trend in the chronic pain industry. Firms in this sector are concentrating on the production of advanced, portable, and user-friendly nerve stimulation devices that employ electric pulses to stimulate nerves and decrease pain. This provides a non-invasive method for managing pain and helps maintain their market position. In December 2022, Abbott Laboratories, an American healthcare company that specializes in diagnostic applications, medical equipment, nutrition, and branded generic pharmaceuticals, introduced Eterna. Eterna is a top-of-the-line spinal cord stimulation (SCS) system and is currently the smallest rechargeable and implantable device in the chronic pain treatment market. Eterna SCS utilizes Abbott’s unique low-dose BurstDR stimulation, the only waveform technology with substantial clinical evidence (1A evidence), showing a 23% higher reduction in pain compared to traditional waveform technology methods.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

What Are the Key Regional Markets in the Chronic Pain Industry?

North America was the largest region in the chronic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11970

This Report Delivers Insight On:

1. How big is the chronic pain market, and how is it changing globally?

2. Who are the major companies in the chronic pain market, and how are they performing?

3. What are the key opportunities and risks in the chronic pain market right now?

4. Which products or customer segments are growing the most in the chronic pain market?

5. What factors are helping or slowing down the growth of the chronic pain market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model